Beijing SL Pharmaceutical Co Ltd Logo

Beijing SL Pharmaceutical Co Ltd (002038): Kapitalflussrechnung

Takani Score ?
26.9

Preis (11.09.2026)52W Hoch52W Tief
5,64 Renminbi Yuan9,383 Renminbi Yuan4,801 Renminbi Yuan
Analysten KonsensBuyOutperformHoldUnderperformSell
12 Renminbi Yuan-----
Externe Analystenschätzungen (Quelle: EODHD) – keine Anlageempfehlung von Takani.
#SharesShort [%]Short Ratio
1.027.350.000--

ℹ️
Interaktive Darstellung: Klicke auf beliebige Zeilen, um eine grafische Entwicklung über die Zeit anzuzeigen.
Kennzahl in 1000 CNY
2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-31
Umsatz
623.643,929660.419,6031.018.358,6961.050.165,4241.214.810,5241.112.733,8022.029.703,6582.167.471,6681.242.076,2681.009.847,4121.156.548,151.242.951,5231.161.778,7471.007.017,782622.772,165457.842,025390.024,556358.002,928237.530,969143.936,377118.557,67493.051,49871.050,80549.904,72832.183,043
Cashflow aus operativer Geschäftstätigkeit
257.663,269225.487,183460.197,296389.820,9464.629,521415.837,437665.826,611485.173,51380.724,354396.861,456504.870,454465.004,184347.413,924398.595,751228.591,711238.134,139174.405,16194.321,16888.363,10457.552,51147.481,05631.262,28630.554,114--
Operative Cashflow Marge
41,32%34,14%45,19%37,12%38,25%37,37%32,8%22,38%30,65%39,3%43,65%37,41%29,9%39,58%36,71%52,01%44,72%54,28%37,2%39,98%40,05%33,6%43%-%-%
Investitionsausgaben (CapEx)
192.971,731347.381,799218.359,623163.487,43236.910,336255.948,054272.782,35227.374,37229.649,344164.211,515129.680,309151.011,019109.478,474247.892,26273.050,09943.044,82330.456,49923.607,99326.612,26764.946,46881.242,31117.734,13116.433,457--
Cashflow aus Investitionstätigkeit
--211.549,874-344.650,432-540.403,356-197.821,293-842.142,395-383.175,828-415.668,43221.037,807-570.661,424243.514,315-287.002,501-150.067,262-248.434,926-82.497,82-164.433,087-136.231,782-18.933,181.143,74321.225,173-247.942,178-17.764,131-30.433,457--
Cashflow aus Finanzierungstätigkeit
--154.102,5-102.735-102.735-103.333,378-206.924,674-198.953,079-342.450-134.690-124.150-122.980-94.835,809-94.927,485-62.639,78-19.203,2-45.931,6-40.860-11.447,661-13.240,339-3.602,2-11.959,192192.425,19420.087,921--
Freier Cashflow
64.691,539-121.894,616241.837,673226.333,47227.719,185159.889,383393.044,261257.799,14151.075,01232.649,941375.190,145313.993,165237.935,45150.703,489155.541,612195.089,316143.948,661170.713,17561.750,837-7.393,957-33.761,25513.528,15514.120,657--
Freie Cashflow Marge
10,37%-18,46%23,75%21,55%18,75%14,37%19,36%11,89%12,16%23,04%32,44%25,26%20,48%14,97%24,98%42,61%36,91%47,68%26%-5,14%-28,48%14,54%19,87%-%-%
Ausgeschüttete Dividenden
-17.895,319-154.102,5-102.735-102.735-102.735-205.470-547.920-342.450-136.980-136.980-136.980-91.368-95.177,485-76.140-63.245-50.280-49.680-12.427,661-13.240,339-8.280-13.802,592-4.700,797-185,379--
Neuausgabe und Rückkäufe von Stammaktien
-------------------------

Kennzahlen dieser Seite im Lexikon

Weitere Informationen findest du im Takani-Lexikon.

Zum vollständigen Lexikon